• Medicine 1

    When patients are involved, medical research results become meaningful solutions

  • Medicine 2

    We provide patient input to the latest research for chronic diseases

  • Medicine 3

    Improving patient knowledge and involvement in clinical trials

EU Summit on airways diseases, air pollution and mobile health
Digital tools are already part of our daily life, whether they are mobile applications or connected machines. In health, digital tools can play a key role in allowing guided self-management, leading t ...

Read more

EMA update on medicines for COPD and eczema
The European Medicines Agency Committee for Medical Products for Human Use (CHMP), responsible for human medicines, has granted a positive opinion on the medical products Riarify and Trydoni ...

Read more

EFA launches Atopic Eczema working group
The needs and lives of patients living with atopic eczema are very specific sometimes, that is why at EFA we are happy to announce the launch of a  working group on Atopic Eczema. The working gro ...

Read more

Higher grades for the Swedes studying in rooms with clean air
There seems to be a connection between indoor air quality in classrooms and school results in Sweden. EFA member Swedish Asthma and Allergy Association went through the country's best schools list in  ...

Read more

Join French allergy patients to get access to desensitisation treatments
EFA member AFPRAL (in French, l’Association Française pour la Prévention des Allergies) launched in January a campaign defending the reimbursement for allergy desensitisation treatments. French heal ...

Read more

Go to vote, but without allergens
Finnish EFA member Allergy, Skin and Asthma Federation updated their poster for the Finnish presidential and other upcoming elections. In Finland, the polling stations are usually situated in school p ...

Read more

Irish patients will not breathe smoky coal anymore
On the 5th December, the Irish National Minister for Communications, Climate Action and Environment, Denis Naughten, announced a full Smoky Coal Ban for Ireland. Bituminous, or smoky, coal creates d ...

Read more

EFA among the few patients representatives at GARD
EFA participated in the global GARD (Global Alliance against Chronic Respiratory Diseases) meeting 2017 that took place in Brussels, Belgium the 9-11 November, represented by EFA Secretary of the Boar ...

Read more

Looking for better outcomes for upper airways patients - European Rhinology Health Forum
EFA represented patients at the European Rhinology Research Forum 2017 on 9-10 November 2017, organized by the European Forum for Research and Education in Allergy and Airway diseases (EUFOREA) and&nb ...

Read more

How to assess the risk of unintended allergens in food?
Our member Deutscher Allergie- und Asthmabund e.V. (DAAB) represented EFA at the 14th November roundtable with NGOs organized by the European Food Security Agency (EFSA) to exchange best practices and ...

Read more

”No perfume in public places, please”, say the Swedes
EFA member Swedish Asthma and Allergy Association celebrated this November the Non Fragance Week. Fragrances can make people with asthma or allergy get sick easier so that is why the campaign, arrange ...

Read more

EFA Finnish member also covers now rare skin diseases
EFA members have got to know the Finnish federation for being specialised in allergies and asthma. After being united with the Finnish Association for Skin Patients in March 2017, the target group of  ...

Read more

EFA participates at the Paediatric Allergy and Asthma Meeting 2017
EFA president Mikaela Odemyr participated in the Paediatric Allergy and Asthma Meeting - PAAM 2017 in London last 26 - 28 October, organised by the European Academy of Allergy and Clinical Immunology  ...

Read more

EFA Patients at the leading respiratory (ERS) and dermatology (EADV) congresses
EFA Patients travelled in a delegation of five to the European Respiratory Congress to present our patients perspective on allergy, asthma and COPD to a public of more than 20,000 participants from in ...

Read more

A total of 4.832 signatures for Allergy and Asthma patients
The 30 September was the last day to sign #CallAllergyAsthma, the political call for European action to improve prevention, care and research on allergy and asthma. The results are impressive!  ...

Read more

EU’s future: patients have a say
EFA has participated to the ongoing discussion on the future of the European Union, a debate set back in March with the European Commission White Paper on the Future of Europe. EFA provided a formal c ...

Read more

New updates on U-BIOPRED, supported by EFA
The U-BIOPRED (Unbiased BIOmarkers in PREDiction of respiratory disease outcomes) outcomes, in which EFA contributed, have been summarised in an interview published by European Respiratory & Pulmo ...

Read more

Swedish patients ask the government to establish national goals for people with chronic diseases
¨People with chronic diseases should be high-lighted," stated the Swedish Asthma and Allergy Association towards the Swedish government. EFA member, the Swedish Asthma and Allergy Association believes ...

Read more

Bulgarian patients organise a concert to inform about of air pollution
EFA member, the Association of Bulgarians with Bronchial Asthma, Allergy and COPD (ABBA), organised on 2nd September an acoustic concert in the cave "God's eyes" under the title "Better air for better ...

Read more

Sign up and join the march for the more than 300 million people with Allergy and Asthma
You are still on time to join the 4,200 signatories of the Call to Action on Allergy and Asthma Sign now! http://www.callallergyasthma.eu/

What's new - Clinical trials

In March we travelled to the UK and kicked-off our new project “Severely, Asthma!”, a video series that explores the different issues impacting the life of severe asthma patients. Severe asthma is sub ...

Read more...

EFA's Roberta Savli participated on the 25th of January in the Stakeholder Forum meeting of the BBMRI-ERIC. The meeting served to identify the priorities of action and to organize and agree on the wor ...

Read more...

Latest research - Clinical trials

EFA organised the final event of AirPROM, an EU funded project that during five years has pulled out the best knowledge of lung research in Europe to come up with a virtual model of the human lungs. E ...

Read more...

On the 9th of September, the Chair of the EFA COPD Working Group, Michael Wilken, represented COPD patients’ views on the IMI GetReal COPD case study workshop held in Frankfurt, Germany. Launched in ...

Read more...

Key Facts

4,000 clinical trials
are authorised each year in the European Economic Area (EEA)

61% of clinical trials
are sponsored by the pharmaceutical industry

39% of clinical trials
are sponsored by non-commercial sponsors, mainly academia